Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1998 1
1999 1
2001 2
2002 3
2003 2
2004 1
2005 1
2006 2
2007 2
2008 2
2009 2
2010 3
2011 4
2012 4
2013 8
2014 7
2015 8
2016 8
2017 9
2018 20
2019 13
2020 29
2021 40
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting.
Rock EM, Limebeer CL, Pertwee RG, Mechoulam R, Parker LA. Rock EM, et al. Cannabis Cannabinoid Res. 2021 Aug;6(4):266-274. doi: 10.1089/can.2021.0041. Epub 2021 Jun 11. Cannabis Cannabinoid Res. 2021. PMID: 34115951 Review.
Introduction: Nausea and vomiting are the most distressing symptoms reported by oncology patients undergoing anticancer treatment. ...Discussion: Here we review in vitro and in vivo evidence for the effectiveness of the nonpsychoactive cannabinoid cannabidiol (CBD) …
Introduction: Nausea and vomiting are the most distressing symptoms reported by oncology patients undergoing anticancer treatment. .. …
Medical Use of Cannabinoids.
Fraguas-Sánchez AI, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Drugs. 2018. PMID: 30374797 Review.
Its involvement in several physiological processes is well known, such as in energy balance, appetite stimulation, blood pressure, pain modulation, embryogenesis, nausea and vomiting control, memory, learning and immune response, among others, as well as in pathological co …
Its involvement in several physiological processes is well known, such as in energy balance, appetite stimulation, blood pressure, pain modu …
Constituents of Cannabis Sativa.
Rock EM, Parker LA. Rock EM, et al. Adv Exp Med Biol. 2021;1264:1-13. doi: 10.1007/978-3-030-57369-0_1. Adv Exp Med Biol. 2021. PMID: 33332000 Review.
There are more than 550 chemical compounds in cannabis, with more than 100 phytocannabinoids being identified, including delta(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). These phytocannabinoids work by binding to the cannabinoid receptors, as well as other recept …
There are more than 550 chemical compounds in cannabis, with more than 100 phytocannabinoids being identified, including delta(9)-tetrahydro …
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Grimison P, Mersiades A, Kirby A, Lintzeris N, Morton R, Haber P, Olver I, Walsh A, McGregor I, Cheung Y, Tognela A, Hahn C, Briscoe K, Aghmesheh M, Fox P, Abdi E, Clarke S, Della-Fiorentina S, Shannon J, Gedye C, Begbie S, Simes J, Stockler M. Grimison P, et al. Ann Oncol. 2020 Nov;31(11):1553-1560. doi: 10.1016/j.annonc.2020.07.020. Epub 2020 Aug 13. Ann Oncol. 2020. PMID: 32801017 Free article. Clinical Trial.
BACKGROUND: This multicentre, randomised, double-blinded, placebo-controlled, phase II/III trial aimed to evaluate an oral THC:CBD (tetrahydrocannabinol:cannabidiol) cannabis extract for prevention of refractory chemotherapy-induced nausea and vomiting (CINV). ...CO …
BACKGROUND: This multicentre, randomised, double-blinded, placebo-controlled, phase II/III trial aimed to evaluate an oral THC:CBD (tetrahyd …
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.
Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L. Pellati F, et al. Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Biomed Res Int. 2018. PMID: 30627539 Free PMC article. Review.
., such as delta(9)-tetrahydrocannabinol (delta(9)-THC) and cannabidiol (CBD), and their effects on inflammation and cancer-related pain. The National Cancer Institute (NCI) currently recognizes medicinal C. sativa as an effective treatment for providing relief in a number …
., such as delta(9)-tetrahydrocannabinol (delta(9)-THC) and cannabidiol (CBD), and their effects on inflammation and cancer-related p …
A selective review of medical cannabis in cancer pain management.
Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, Chow E, O'Hearn S. Blake A, et al. Ann Palliat Med. 2017 Dec;6(Suppl 2):S215-S222. doi: 10.21037/apm.2017.08.05. Epub 2017 Aug 23. Ann Palliat Med. 2017. PMID: 28866904 Free article. Review.
This review presents a selection of representative clinical studies, from small pilot studies conducted in 1975, to double-blind placebo-controlled trials conducted in 2014 that evaluated the efficacy of cannabinoid-based therapies containing tetrahydrocannabinol (THC) and can …
This review presents a selection of representative clinical studies, from small pilot studies conducted in 1975, to double-blind placebo-con …
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. Taylor L, et al. CNS Drugs. 2018 Nov;32(11):1053-1067. doi: 10.1007/s40263-018-0578-5. CNS Drugs. 2018. PMID: 30374683 Free PMC article. Clinical Trial.
BACKGROUND: A formal single ascending and multiple dose pharmacokinetic (PK) trial of cannabidiol (CBD) oral solution was required to determine the safety and tolerability of CBD, the maximum tolerated dose, and to examine the effect of food on CBD PK parameters. ...All su …
BACKGROUND: A formal single ascending and multiple dose pharmacokinetic (PK) trial of cannabidiol (CBD) oral solution was required to …
Cannabis Use, Lung Cancer, and Related Issues.
Jett J, Stone E, Warren G, Cummings KM. Jett J, et al. J Thorac Oncol. 2018 Apr;13(4):480-487. doi: 10.1016/j.jtho.2017.12.013. Epub 2018 Jan 31. J Thorac Oncol. 2018. PMID: 29374567 Free article. Review.
Increasing evidence supports cannabis in the management of chemotherapy-induced nausea and vomiting (CINV) and for pain management; however, studies are limited, particularly by difficulties associated with standardized dosing estimates and inability to accurately assess b …
Increasing evidence supports cannabis in the management of chemotherapy-induced nausea and vomiting (CINV) and for pain management; h …
Cannabinoid hyperemesis syndrome.
Galli JA, Sawaya RA, Friedenberg FK. Galli JA, et al. Curr Drug Abuse Rev. 2011 Dec;4(4):241-9. doi: 10.2174/1874473711104040241. Curr Drug Abuse Rev. 2011. PMID: 22150623 Free PMC article. Review.
Cannabinoid Hyperemesis Syndrome is characterized by chronic cannabis use, cyclic episodes of nausea and vomiting, and frequent hot bathing. Cannabinoid Hyperemesis Syndrome occurs by an unknown mechanism. ...Patients often demonstrate the learned behavior of frequent hot …
Cannabinoid Hyperemesis Syndrome is characterized by chronic cannabis use, cyclic episodes of nausea and vomiting, and frequent hot b …
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Sarris J, et al. BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8. BMC Psychiatry. 2020. PMID: 31948424 Free PMC article.
Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known. ...Isolated positive …
Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and …
161 results